Regulation of Postnatal Trabecular Bone Formation by the Osteoblast Endothelin A Receptor

被引:24
作者
Clines, Gregory A. [1 ,2 ,3 ]
Mohammad, Khalid S. [3 ]
Grunda, Jessica M.
Clines, Katrina L. [3 ]
Niewolna, Maria [3 ]
McKenna, C. Ryan [3 ]
McKibbin, Christopher R. [3 ]
Yanagisawa, Masashi [4 ,5 ]
Suva, Larry J. [6 ]
Chirgwin, John M. [3 ]
Guise, Theresa A. [3 ]
机构
[1] Univ Alabama Birmingham, Dept Med, Birmingham VA Med Ctr, Div Endocrinol Diabet & Metab,Endocrinol Sect, Birmingham, AL 35294 USA
[2] Vet Affairs Med Ctr, Birmingham, AL USA
[3] Univ Virginia, Dept Med, Div Endocrinol & Metab, Charlottesville, VA USA
[4] Univ Texas SW Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA
[5] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA
[6] Univ Arkansas Med Sci, Ctr Orthopaed Res, Dept Orthopaed Surg, Little Rock, AR 72205 USA
基金
美国安德鲁·梅隆基金会;
关键词
ENDOTHELIN A RECEPTOR; ENDOTHELIN-1; OSTEOBLAST; BONE; SEX STEROIDS; SITE-SPECIFIC REGULATION; QUANTITATIVE TRAIT LOCI; ANDROGEN DEPRIVATION; GROWTH; THERAPY; MICE; DENSITY; OSTEOPOROSIS; DEFICIENT; KNOCKOUT;
D O I
10.1002/jbmr.450
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Endothelin-1 (ET-1) is a potent vasoconstrictor that also stimulates cells in the osteoblast lineage by binding to the endothelin A receptor (ETAR). ET-1 ligand is widely secreted, particularly by the vasculature. However, the contributions of ETAR signaling to adult bone homeostasis have not been defined. ETAR was inactivated in osteoblasts by crossing ETAR-floxed and osteocalcin-Cre mice. Histomorphometric analyses were performed on 4-, 8-, and 12-week-old osteoblast-targeted ETAR knockout (KO) and wild-type (WT) male and female mice. Tibial trabecular bone volume was significantly lower from 12 weeks in KO versus WT mice in both males and females. Bone-formation rate, osteoblast density, and in vitro osteoblast differentiation were reduced by targeted inactivation of ETAR. A separate longitudinal analysis was performed between 8 and 64 weeks to examine the effect of aging and castration on bone metabolism in ETAR KO mice. Hypogonadism did not change the rate of bone accrual in WT or KO females. However, eugonadal KO males had a significantly larger increase in tibial and femoral bone acquisition than WT mice. Male mice castrated at: 8 weeks of age showed the reverse: KO mice had reduced rates of tibial and femoral BMD acquisition compared with WT mice. In vitro, ET-1 increased osteoblast proliferation, survival, and differentiation. Dihydrotestosterone also increased osteoblast differentiation using a mechanism distinct from the actions of ET-1. These results demonstrate that endothelin signaling in osteoblasts is an important regulator of postnatal trabecular bone remodeling and a modulator of androgen effects on bone. (C) 2011 American Society for Bone and Mineral Research.
引用
收藏
页码:2523 / 2536
页数:14
相关论文
共 47 条
[1]
Guidelines for Assessment of Bone Microstructure in Rodents Using Micro-Computed Tomography [J].
Bouxsein, Mary L. ;
Boyd, Stephen K. ;
Christiansen, Blaine A. ;
Guldberg, Robert E. ;
Jepsen, Karl J. ;
Mueller, Ralph .
JOURNAL OF BONE AND MINERAL RESEARCH, 2010, 25 (07) :1468-1486
[2]
QTL analysis of trabecular bone in BXD F2 and RI mice [J].
Bower, Abbey L. ;
Lang, Dean H. ;
Vogler, George P. ;
Vandenbergh, David J. ;
Blizard, David A. ;
Stout, Joseph T. ;
McClearn, Gerald E. ;
Sharkey, Neil A. .
JOURNAL OF BONE AND MINERAL RESEARCH, 2006, 21 (08) :1267-1275
[3]
High bone density due to a mutation in LDL-receptor-related protein 5 [J].
Boyden, LM ;
Mao, JH ;
Belsky, J ;
Mitzner, L ;
Farhi, A ;
Mitnick, MA ;
Wu, DQ ;
Insogna, K ;
Lifton, RP .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (20) :1513-1521
[4]
A phase 3 randomized controlled trial of the efficacy and safety of atrasentan in men with metastatic hormone-refractory prostate cancer [J].
Carducci, Michael A. ;
Saad, Fred ;
Abrahamsson, Per-Anders ;
Dearnaley, David R. ;
Schulman, Claude C. ;
North, Scott A. ;
Sleep, Darryl J. ;
Isaacson, Jeffrey D. ;
Nelson, Joel B. .
CANCER, 2007, 110 (09) :1959-1966
[5]
Clines Gregory A., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000616
[6]
Dickkopf homolog 1 mediates endothelin-1-stimulated new bone formation [J].
Clines, Gregory A. ;
Mohammad, Khalid S. ;
Bao, Yongde ;
Stephens, Owen W. ;
Suva, Larry J. ;
Shaughnessy, John D., Jr. ;
Fox, Jay W. ;
Chirgwin, John M. ;
Guise, Theresa A. .
MOLECULAR ENDOCRINOLOGY, 2007, 21 (02) :486-498
[7]
Clouthier DE, 1998, DEVELOPMENT, V125, P813
[8]
Bone-specific growth inhibition of prostate cancer metastasis by atrasentan [J].
Drake, Justin M. ;
Danke, Joshua R. ;
Henry, Michael D. .
CANCER BIOLOGY & THERAPY, 2010, 9 (08) :607-614
[9]
Ambrisentan therapy for pulmonary arterial hypertension [J].
Galié, N ;
Badesch, D ;
Oudiz, R ;
Simonneau, G ;
McGoon, MD ;
Keogh, AM ;
Frost, AE ;
Zwicke, D ;
Naeije, R ;
Shapiro, S ;
Olschewski, H ;
Rubin, LJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 46 (03) :529-535
[10]
GASSER JA, 2003, BONE RES PROTOCOLS, P323